Learning Objectives
Upon completion of this activity, participants should be able to:
Review the indications and contraindications of agents used to treat chronic hepatitis B.
Evaluate the guidelines for instituting therapy in patients with HBeAg-negative chronic hepatitis B.
Discuss the challenges of long-term treatment of chronic hepatitis B.
Review the approach to a patient who develops resistance to HBV therapy.
A 43-Year-Old Man With Asymptomatic HBeAg-Negative Disease